Holen Sie sich die Stockscreener-App
14.06
1.66%
0.23
Handel nachbörslich:
13.78
-0.28
-1.99%
Schlusskurs vom Vortag:
$13.83
Offen:
$13.96
24-Stunden-Volumen:
34,464
Relative Volume:
1.10
Marktkapitalisierung:
$28.78M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-4.85M
KGV:
-45.35
EPS:
-0.31
Netto-Cashflow:
$-3.95M
1W Leistung:
+2.03%
1M Leistung:
+8.49%
6M Leistung:
-19.47%
1J Leistung:
+9.08%
1-Tages-Spanne:
$13.80
$14.15
1-Wochen-Bereich:
$13.24
$14.64
52-Wochen-Spanne:
$8.74
$22.90
Cadrenal Therapeutics Inc Stock (CVKD) Company Profile
Firmenname
Cadrenal Therapeutics Inc
Sektor
Branche
Telefon
904-300-0701
Adresse
822 A1A NORTH, PONTE VEDRA
Vergleichen Sie CVKD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CVKD
Cadrenal Therapeutics Inc
|
14.06 | 28.31M | 0 | -4.85M | -3.95M | -0.31 |
|
VRTX
Vertex Pharmaceuticals Inc
|
404.21 | 100.41B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
599.94 | 59.59B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.65 | 59.77B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
767.33 | 45.14B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
335.16 | 37.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Cadrenal Therapeutics Inc Stock (CVKD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-12-18 | Eingeleitet | Noble Capital Markets | Outperform |
Cadrenal Therapeutics Inc Aktie (CVKD) Neueste Nachrichten
Cadrenal Therapeutics Inc. stock daily chart insightsPortfolio Return Report & Low Risk High Reward Trade Ideas - newser.com
Can Cadrenal Therapeutics Inc. stock beat market expectations this quarter - newser.com
CVKD: Acquires Factor XIa Inhibitors - Smartkarma
CVKD: Acquires Factor XIa Inhibitors… - Yahoo Finance
Backtesting results for Cadrenal Therapeutics Inc. trading strategiesMarket Sentiment Report & Free Growth Oriented Trading Recommendations - newser.com
Will a bounce in Cadrenal Therapeutics Inc. offer an exitWeekly Investment Recap & Consistent Return Investment Signals - newser.com
Can Cadrenal Therapeutics Inc. stock sustain institutional interestFed Meeting & Growth Focused Stock Pick Reports - newser.com
Cadrenal Therapeutics Inc Stock Analysis and ForecastVolume Analysis Techniques & Hidden Gems with Outstanding Profit Margins - earlytimes.in
Cadrenal Therapeutics to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025 - GlobeNewswire
Anticoagulation Therapy Biotech Cadrenal Therapeutics to Showcase Pipeline at Lytham Investor Conference - Stock Titan
Published on: 2025-09-30 10:26:28 - earlytimes.in
Custom watchlist performance reports with Cadrenal Therapeutics Inc.Weekly Trading Summary & AI Optimized Trade Strategies - newser.com
Multi factor analysis applied to Cadrenal Therapeutics Inc.2025 Support & Resistance & Daily Profit Maximizing Trade Tips - newser.com
What analysts say about Cadrenal Therapeutics Inc stockLow Beta Stocks & High Return Trading Ideas - earlytimes.in
Cadrenal therapeutics (CVKD) CEO Pham sells $131,779 in stock By Investing.com - Investing.com South Africa
Cadrenal therapeutics (CVKD) CEO Pham sells $131,779 in stock - Investing.com India
Szot, CFO of Cadrenal, sells $174k in CVKD stock - Investing.com India
Is Cadrenal Therapeutics Inc. stock attractive for income investorsMarket Activity Summary & Expert Verified Stock Movement Alerts - newser.com
Can EFC$D stock test all time highsTrade Signal Summary & Daily Profit Maximizing Tips - newser.com
Cadrenal Therapeutics Elects New Director at Meeting - TipRanks
Should you hold or exit Conduit Pharmaceuticals Inc. Equity Warrant nowNew Guidance & Smart Money Movement Alerts - newser.com
Can Cadrenal Therapeutics Inc. rally from current levels2025 Geopolitical Influence & Low Risk Entry Point Tips - newser.com
Is now a turning point for Cadrenal Therapeutics Inc.Earnings Trend Report & Daily Profit Maximizing Tips - newser.com
How does Apollomics Inc Equity Warrant compare to its peers2025 Risk Factors & Low Volatility Stock Suggestions - خودرو بانک
How to monitor Cadrenal Therapeutics Inc. with trend dashboards2025 Trade Ideas & Weekly Top Performers Watchlists - newser.com
Market Pulse: What is the next catalyst for Cadrenal Therapeutics Inc2025 Trading Volume Trends & Real-Time Sentiment Analysis - خودرو بانک
Resistance Check: Should I average down on MaxCyte Inc stockMarket Activity Summary & Stepwise Entry/Exit Trade Alerts - khodrobank.com
Short Squeeze: Is Cadrenal Therapeutics Inc. a top pick in the sectorLong Setup & AI Powered Market Entry Strategies - خودرو بانک
Energy Moves: Whats the profit margin of EWBCTrade Entry Report & Daily Growth Stock Investment Tips - خودرو بانک
Is it time to cut losses on Cadrenal Therapeutics Inc.Quarterly Market Summary & AI Forecast for Swing Trade Picks - newser.com
Trend analysis for Ideal Power Inc. this week2025 Earnings Impact & Momentum Based Trading Ideas - newser.com
Finanzdaten der Cadrenal Therapeutics Inc-Aktie (CVKD)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.95%
1.63%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):